InflaRx NV (IFRX)

0.8947 +0.02 (+2.51%) USD  |  NASDAQ  |  Feb 20, 16:00
0.89 0.00 (0.00%) Pre-Market: 20:00
More

InflaRx Current Deferred Tax Liability (Quarterly)

Current Deferred Tax Liability (Quarterly) Chart

View Current Deferred Tax Liability (Quarterly) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Tax Liability (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Tax Liability (Quarterly) Range, Past 5 Years

View Current Deferred Tax Liability (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Tax Liability (Quarterly) Benchmarks

View Current Deferred Tax Liability (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. --
Liminatus Pharma, Inc. --
Oruka Therapeutics, Inc. --
Maze Therapeutics, Inc. --